Praxis Precision Medicines (PRAX) Profit After Tax (2019 - 2026)
Praxis Precision Medicines (PRAX) posted quarterly Profit After Tax of -$92.6 million for Q1 2026, down 33.63% year-over-year from -$139.5 million in Q1 2025, and down 4.11% quarter-over-quarter from -$88.9 million in Q4 2025.
Praxis Precision Medicines (PRAX) Profit After Tax (2019 - 2026) Analysis & Trends
Praxis Precision Medicines' Profit After Tax history runs 8 years deep, the most recent figure standing at -$92.6 million for Q1 2026.
- In Q1 2026, Profit After Tax fell 33.63% year-over-year to -$92.6 million; the TTM figure through Mar 2026 stood at -$326.6 million (down 53.65% YoY), while the FY2025 annual figure was -$303.3 million, down 65.9% from the prior year.
- Profit After Tax for Q1 2026 stood at -$92.6 million, down from -$88.9 million in the prior quarter.
- The five-year high for Profit After Tax was -$24.6 million in Q3 2023, with the low at -$92.6 million in Q1 2026.
- The 5-year median for Profit After Tax is -$51.9 million (2024), against an average of -$53.9 million.
- The sharpest annual moves came in 2022 and 2023: Profit After Tax slumped 151.04% in 2022, then surged 45.49% in 2023.
- Praxis Precision Medicines' Profit After Tax stood at -$41.2 million in 2022, then soared by 34.72% to -$26.9 million in 2023, then plunged by 118.32% to -$58.7 million in 2024, then tumbled by 51.58% to -$88.9 million in 2025, then dropped by 4.11% to -$92.6 million in 2026.
- Business Quant data shows PRAX's Profit After Tax at -$92.6 million in Q1 2026, -$88.9 million in Q4 2025, and -$73.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 472.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,087.27 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Praxis Precision Medicines | 10.24 Bn | 9.48 Bn | - | -84.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -84.80 Mn |
| Mar 31, 2026 | -92.60 Mn |
| Dec 31, 2025 | -88.94 Mn |
| Sep 30, 2025 | -73.93 Mn |
| Jun 30, 2025 | -71.13 Mn |
| Mar 31, 2025 | -69.30 Mn |
| Dec 31, 2024 | -58.68 Mn |
| Sep 30, 2024 | -51.91 Mn |
| Jun 30, 2024 | -32.68 Mn |
| Mar 31, 2024 | -39.55 Mn |
| Dec 31, 2023 | -26.88 Mn |
| Sep 30, 2023 | -24.63 Mn |
| Jun 30, 2023 | -34.31 Mn |
| Mar 31, 2023 | -37.46 Mn |
| Dec 31, 2022 | -41.17 Mn |
| Sep 30, 2022 | -43.95 Mn |
| Jun 30, 2022 | -60.19 Mn |
| Mar 31, 2022 | -68.72 Mn |
| Dec 31, 2021 | -58.58 Mn |
| Sep 30, 2021 | -44.71 Mn |